Add-on Acquisition • Life Science

Taran Therapeutics Acquires Humanigen

On September 25, 2024, Taran Therapeutics acquired life science company Humanigen for 2M USD

Acquisition Context

This is Taran Therapeutics’ 1st transaction in the Life Science sector.
This is Taran Therapeutics’ largest (disclosed) transaction.
This is Taran Therapeutics’ 1st transaction in the United States.
This is Taran Therapeutics’ 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 25, 2024
Target	Humanigen
Sector	Life Science
Buyer(s)	Taran Therapeutics
Deal Type	Add-on Acquisition
Deal Value	2M USD
Advisor(s)	SC&H (Financial)

Target Company

Humanigen

Short Hills, California, United States

Humanigen is a bio-pharmaceutical company. Humanigen was founded in 2000 and is based in Short Hills, New Jersey.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Taran Therapeutics

San Francisco, California, United States

Category	Company
Sector	Life Science

DESCRIPTION

Taran Therapeutics is a privately-owned biotech pioneering late-stage therapy for hematology/oncology and chronic inflammation. Taran Therapeutics is based in San Francisco, California.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2024	1 of 1
Size (of disclosed)	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2024 M&A